1. Home
  2. AKRO vs GNL Comparison

AKRO vs GNL Comparison

Compare AKRO & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akero Therapeutics Inc.

AKRO

Akero Therapeutics Inc.

HOLD

Current Price

$54.65

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Logo Global Net Lease Inc.

GNL

Global Net Lease Inc.

HOLD

Current Price

$8.29

Market Cap

1.7B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKRO
GNL
Founded
2017
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
1.7B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
AKRO
GNL
Price
$54.65
$8.29
Analyst Decision
Buy
Buy
Analyst Count
11
2
Target Price
$73.56
$9.00
AVG Volume (30 Days)
2.4M
1.3M
Earning Date
11-07-2025
11-05-2025
Dividend Yield
N/A
9.18%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$751,333,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.63
52 Week Low
$21.34
$6.51
52 Week High
$58.40
$8.40

Technical Indicators

Market Signals
Indicator
AKRO
GNL
Relative Strength Index (RSI) 68.63 62.14
Support Level $54.30 $8.20
Resistance Level $54.70 $8.40
Average True Range (ATR) 0.17 0.13
MACD -0.10 0.01
Stochastic Oscillator 71.07 82.47

Price Performance

Historical Comparison
AKRO
GNL

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About GNL Global Net Lease Inc.

Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.

Share on Social Networks: